As of 2025-07-09, the Intrinsic Value of Phio Pharmaceuticals Corp (PHIO) is -7.05 USD. This PHIO valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.50 USD, the upside of Phio Pharmaceuticals Corp is -382.08%.
Based on its market price of 2.50 USD and our intrinsic valuation, Phio Pharmaceuticals Corp (PHIO) is overvalued by 382.08%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -7.05 - -7.05 | -7.05 | -382.08% |
| P/E | (19.89) - (31.03) | (26.83) | -1173.3% |
| DDM - Stable | (13.68) - (174.78) | (94.23) | -3869.2% |
| DDM - Multi | (13.13) - (138.26) | (24.54) | -1081.7% |
| Market Cap (mil) | 12.00 |
| Beta | 3.13 |
| Outstanding shares (mil) | 4.80 |
| Enterprise Value (mil) | -1.28 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.97% |
| Cost of Debt | 5.00% |
| WACC | 5.82% |